Efficient aerial oxidation of different types of alcohols using ZnO nanoparticle–MnCO3-graphene oxide composites

Graphene–metal nanocomposites have been found to remarkably enhance the catalytic performance of metal nanoparticle-based catalysts. In continuation of our previous report, in which highly reduced graphene oxide (HRG)-based nanocomposites were synthesized and evaluated, we present nanocomposites of graphene oxide (GRO) and ZnO nanoparticle-doped MnCO₃ ([ZnO–MnCO₃/(1%)GRO]) synthesized via a facile, straightforward co-precipitation technique. Interestingly, it was noticed that the incorporation of GRO in the catalytic system could noticeably improve the catalytic efficiency compared to a catalyst (ZnO–MnCO₃) without GRO, for aerial oxidation of benzyl alcohol (BzOH) employing O₂ as a nature-friendly oxidant under base-free conditions. The impacts of various reaction factors were thoroughly explored to optimize reaction conditions using oxidation of BzOH to benzaldehyde (BzH) as a model substrate. The catalysts were characterized using X-ray diffraction, thermogravimetric analysis, Fourier transform infrared spectroscopy, field-emission scanning electron microscopy, Energy dispersive X-ray spectroscopy (EDX), Brunauer-Emmett-Teller (BET), and Raman spectroscopy. The (1%)ZnO–MnCO₃/(1%)GRO exhibited significant specific activity (67 mmol.g⁻¹.hr⁻¹) with full convversion of BzOH and >99% BzH selectivity within just 6 min. The catalytic efficiency of the (1%)ZnO–MnCO₃/(1%)GRO nanocomposite was significantly better than the (1%)ZnO–MnCO₃/(1%)HRG and (1%)ZnO–MnCO₃ catalysts, presumably due to the existence of oxygen-possessing groups on the GRO surface and as well as a very high surface area that could have been instrumental in uniformly dispersing the active sites of the catalyst, i.e., ZnO–MnCO₃. Under optimum circumstances, various kinds of alcohols were selectively transformed to respective carbonyls with full convertibility over the (1%)ZnO–MnCO₃/(1%)GRO catalyst. Furthermore, the highly effective (1%)ZnO–MnCO₃/(1%)GRO catalyst could be successfully reused and recycled over five consecutive runs with a marginal reduction in its performance and selectivity.     

Natural convection of nanoencapsulated phase change suspensions inside a local thermal non-equilibrium porous annulus

Journal of Thermal Analysis and Calorimetry - In this study, the heat transfer, fluid flow and heat capacity ratio are analyzed in an annulus enclosure filled with porous and saturated by a...     

Thermal and hydrodynamic performance of a microchannel heat sink with carbon nanotube nanofluids

Journal of Thermal Analysis and Calorimetry - The method of evaluating the magnetocaloric effect (MCE) and heat capacity of various magnetic samples from calorimetric experiments are presented....     

Transverse energy distributions in Si-nucleus collisions at 10 GeV/nucleon

Transverse energy distributions have been measured for collisions of 10 GeV/nucleon Si with targets of Al, Cu and Pb using a combination of a NaI wall and a uranium based sampling calorimeter. The measured cross sectionsdσ/dE _T anddE _T /dη are consistent with full stopping and an increase, with increasing values ofE _T , of energy flow into large angles.     

Weighted ebyev-Ostrowski type inequalities

In account of the famous ebyev inequality,a rich theory has appeared in the literature.We establish some new weighted ebyev type integral inequalitíes.Our proofs are of independent interest and provide new estimates on these types of inequalities.     

Interaction of a Surface-Active Ionic Liquid with an Antidepressant Drug: Micellization and Spectroscopic Studies

The interaction of the antidepressant drug nortriptyline hydrochloride (NOT) with the surface-active ionic liquid (SAIL), 1-decyl-3-methylimidazolium chloride, [C₁₀mim][Cl], has been studied using multiple techniques, including conductometric titration, tensiometric, fluorometric, dynamic light scattering and UV–visible spectrophotometric measurements. There is a significant decrease in the cmc of SAIL on the addition of the drug NOT, indicating adsorption of drug molecules in the outer portion of the micelle. In the present study, the values of the packing parameter, P, lie in the range of 0–0.3, which suggests that the micelles formed are spherical in nature. More negative values of the standard Gibbs energy of adsorption, \( \Delta G_{\text{ad}}^{ \circ } \), compared to \( \Delta G_{\text{m}}^{ \circ } \) support our contention that adsorption of SAIL on the air-solution interface is relatively more favorable than its micellization in the presence of NOT. Fluorescence and DLS studies indicate that the aggregation number, N_agg, and hydrodynamic radius of SAIL increase with increase in concentration of NOT. The UV–visible spectroscopic study confirms the formation of a new complex between SAIL and NOT; this is also supported by the negative Gibbs energy of complexation.     

Synthesis and characterization of polyaniline–zirconium dioxide and polyaniline–cerium dioxide composites with enhanced photocatalytic degradation of rhodamine B dye

For the first time, chloroform and 2-butanol were used as solvent systems for the preparation of ZrO₂–PANI and CeO₂–PANI composites. Solubility of the synthesized composites was studied in chloroform, N-methyl-2-pyrrolidinone (NMP), and in mixture of toluene?+?2-propanol (2:1). XRD and cyclic voltammetry data showed that the ZrO₂–PANI and CeO₂–PANI composites possess both crystalline and amorphous domains indicating some sort of conductivity. TGA results showed that ZrO₂–PANI composite have a better thermal stability than pure PANI; however, CeO₂–PANI composite has lower thermal stability than pure PANI. The conjugated unsaturated structure of PANI is responsible for the enhanced photocatalytic properties of ZrO₂–PANI and CeO₂–PANI. Photocatalytic results showed that, at photolysis time of 60 min, rhodamine B (RhB) dye was degraded up to 34 and 35% by ZrO₂–PANI and CeO₂–PANI, respectively. The degradation products of RhB were quantified by LC–MS and GC–MS, and accordingly, a detailed pathway was proposed.     

An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant

The aspartate protease of the human immune deficiency type-1 virus (HIV-1) has become a crucial antiviral target in which many useful antiretroviral inhibitors have been developed. However, it seems the emergence of new HIV-1 PR mutations enhances drug resistance, hence, the available FDA approved drugs show less activity towards the protease. A mutation and insertion designated L38L↑N↑L PR was recently reported from subtype of C-SA HIV-1. An integrated two-layered ONIOM (QM:MM) method was employed in this study to examine the binding affinities of the nine HIV PR inhibitors against this mutant. The computed binding free energies as well as experimental data revealed a reduced inhibitory activity towards the L38L↑N↑L PR in comparison with subtype C-SA HIV-1 PR. This observation suggests that the insertion and mutations significantly affect the binding affinities or characteristics of the HIV PIs and/or parent PR. The same trend for the computational binding free energies was observed for eight of the nine inhibitors with respect to the experimental binding free energies. The outcome of this study shows that ONIOM method can be used as a reliable computational approach to rationalize lead compounds against specific targets. The nature of the intermolecular interactions in terms of the host–guest hydrogen bond interactions is discussed using the atoms in molecules (AIM) analysis. Natural bond orbital analysis was also used to determine the extent of charge transfer between the QM region of the L38L↑N↑L PR enzyme and FDA approved drugs. AIM analysis showed that the interaction between the QM region of the L38L↑N↑L PR and FDA approved drugs are electrostatic dominant, the bond stability computed from the NBO analysis supports the results from the AIM application. Future studies will focus on the improvement of the computational model by considering explicit water molecules in the active pocket. We believe that this approach has the potential to provide information that will aid in the design of much improved HIV-1 PR antiviral drugs.     

New analogs of temporin-LK1 as inhibitors of multidrug-resistant (MDR) bacterial pathogens

The peptide temporin-LK1 (1) was obtained from the skin secretion of frog Limnonectes kuhlii (Ranidae). It is a unique antimicrobial peptide with 17 residues, including four L-phenylalanines and single glycine. Mass spectrometry and Edmand degradation were used for the determination of sequence of amino acids in temporin-LK 1 (1), and confirmed by cDNA cloning. We report here the synthesis and structural studies of temporin-LK1 (1) and its analogs 2–4. Peptides 2–4 were prepared by substitution of achiral glycine residue of temporin-LK1 (1) with D-alanine, L-phenylglycine, and L-naphthylalanine, respectively. Peptides 1–4 were evaluated against multidrug-resistant (MDR) strains of Staphylococcus aureus and Pseudomonas aeruginosa. Analog 2 was found active against all MDR strains of S. aureus and P. aeruginosa at a much lower dose than the clinically used antibiotics.     

Toxico‐Metabolomics of Engineered Nanomaterials: Progress and Challenges

Nanoscale matter has unique attributes that potentiate their widespread application from biomedicine, engineering, food, cosmetics, sensing, to energy. Due to the rapid industrialization of engineered nanomaterials (ENMs) as a result of increasing consumer interests, more ENMs will be released into the environment, greatly increasing the probability of their contact with humans. Once these ENMs enter the human body or an ecosystem, they may initiate various biochemical responses in unprecedented ways, thus raising important concerns in regard to their effects on human health and the ecosystem. Here, the shifts in the intricate metabolic pathways instigated by ENMs are highlighted and those altered metabolic changes are extrapolated for the elucidation of environmental health and risk assessment. Furthermore, the toxico‐metabolomics knowledge of ENMs provides the opportunity to design novel nanomedicine with high efficacies by capitalizing on their abilities to rewire metabolic networks for the treatment of diseases.